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Summary
After 24 hours, cardiac myocytes exposure to 10 µM (LD50) vanadate(meta or decavanadate) an increased (30%) of caspase 3-activation was ob-
served, although not significant. On contrary, a significant decrease (40%) of
ATP content, characteristic of necrotic cell death was detected. Furthermore,
vanadate treatment increased intracellular Ca2+ level from 60 nM to 240 nM,
whereas it decreases mitochondria superoxide anion generation and induces
mitochondria membrane depolarization (IC50=6.5 µM). In conclusion, micromolar
vanadate exposure induces large chances in two major bioenergetic markers
in cardiac myocytes: intracellular calcium concentration and superoxide anion
mitochondrial production, suggesting a necrotic cell death through a mito-
chondrial toxic pathway.
Introduction
Environmental contamination by toxic metals, in particular by vanadium,
has increased dramatically during the last decades due to the use of fossil
fuels. In spite of the emerging interest in the pharmacological effects of some
vanadium compounds, for instance as an insulin-mimetic, in the treatment of
diabetes, the toxicology of vanadium constitutes an area of increasing inter-
est. Recently, our research group has been carrying out studies about the toxic
effects of vanadate. In vivo studies, shown that the degree of vanadium tox-
icity depends on the mode of administration, such as intraperitoneal or intra-
venous, and is also dependent, at some extend, to the chemical form of va-
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nadium such as decavanadate (1). It was also shown that vanadium is accu-
mulated in hepatic and cardiac muscle cells, inducing changes in lipid peroxidation
and oxidative stress markers. One of the most important results was the ob-
servation that vanadate inhibits mitochondrial oxygen consumption and in-
duces membrane depolarization at the nM range of concentration (2). In an-
other line of research, the effects of vanadate on the mineralization of a bone-
derived cell line were studied and compared to that of insulin. Vanadate (5
µM) was shown to stimulated growth performance and prevents extracellular
matrix mineralization, probably through multiple processes involving regula-
tion that may or may not depend upon the activation of insulin stimulated
pathways (3). Other studies included the use of vanadate as a probe in the
understanding of muscle contraction, calcium homeostasis and actin filaments
dynamics (1). In the present study, we described the mechanisms of cell death
induced by vanadate using cardiomyocytes. Apparently, vanadate induces
necrotic cardiac cell death through impairment of mitochondrial function. We
believe that these recent advances in a better knowledge of vanadium toxicity
allow a better understanding of vanadium effects in biology and pharmacol-
ogy (1).
Materials And Methods
Ventricles from hearts of neonatal (2-days-old) Wistar rats (Rattus norvegicus)
were used. After 3 days in growth medium (DMEM), the cardiomyocytes
were treated with decavanadate (DV) or metavanadate (MV) concentrations
ranging from 0-50 µM (total vanadium). Metavanadate stock solution (50
mM, pH 6.7) was prepared from ammonium metavanadate. Decavanadate
stock solution was obtained by adjusting the pH of the former solution to 4.0.
The composition and stability of the vanadate solutions were analyzed by
NMR and UV/Vis spectroscopy as described elsewhere (1). All experiments
were performed using cardiomyocytes at 3-4 DIV (days in vitro). The purity
of cardiomyocytes cell cultures (~80% of myocytes in culture) was estimated
either by cell counting, immunodetection of myosin heavy chain or
immunostaining. Estimation of viable cells was assessed by measuring the
amount of coloured formazan formed upon the reduction of MTT. Caspase-
3 activity was measured using Ac-DEVDpNA. Adenine nucleotides were
determined spectrophotometrically after extraction with perchloric acid (3.3%)
and neutralization with KOH. Intracellular calcium ([Ca2+]i) was measured
using the fluorescent indicator fura-2. Dihydroethidium (DHE) was used as a
specific dye for superoxide anion. Mitochondrial membrane potential (Ψm)
was monitored in cardiomyocytes with JC-1. The ratios of JC-1 aggregate to
monomer intensity for each region were calculated. A decrease in this ratio
was interpreted as decrease of Ψm, whereas an increase in the ratio was
interpreted as again in Ψm (Soares et al, in revision process).
Results And Discussion
Both vanadate solutions were found to decrease cell viability (not shown).
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MTT assay indicated that 24 h exposure to decavanadate (DV) and metavanadate
(MV) solutions induce a similar loss of cell viability (IC50 = 10 µM total
vanadium). No caspase-3 activation was observed after 12 hours exposure to
decavanadate or metavanadate concentrations. However, 24 hours after and
increase (30%) of caspase activity was detected, although not significant. On
contrary, a significant decrease of the cardiomyocytes energy charge was
observed after 24 h exposure to DV: 10 and 20 µM total vanadium reduced
energy charge by 36% and 39%, respectively, and lower decrease (15%) and
(20%) to the same concentrations of metavanadate. Control cardiac myocytes
(non treated cells) presented a normal low [Ca2+]i in the range of 60±10 nM.
Cardiomyocytes treated for 24 hours with decavanadate or metavanadate (10
µM total vanadium) were able to maintain its intracellular Ca2+ homeostasis
although at higher basal [Ca2+]i, between 200 and 250 nM. Therefore, these
results pointed out that cardiomyocytes exposure to vanadate solutions, either
decavanadate and metavanadate, impaired the balance between calcium up-
take and release by intracellular Ca2+ stores, favouring partial calcium deple-
tion of intracellular stores. The intracellular oxidative stress monitored by
DHE was found to be largely attenuated by exposure of cardiomyocytes to
both vanadate solutions. In fact, a 24 h treatment of cardiomyocytes with 20
µM decavanadate (i.e. 2 µM DV) or metavanadate solutions, reduced anion
superoxide production by 70%. Maintenance of the mitochondrial membrane
potential (Ym) is essential for the normal performance and survival of cells
with a high metabolic energy requirement, such as cardiomyocytes. Mito-
chondrial membrane potential plays a major role in the modulation of calcium
uptake and release by mitochondria in rat ventricular myocytes. Fluorescence
images of cardiomyocytes stained with JC-1 showed that control cells exhib-
ited heterogeneous staining of the cytoplasm with both red (polarized mito-
chondria) and green (depolarized mitochondria) fluorescence co-existing in
the same cell (not shown). Consistent with mitochondrial localization, the red
fluorescence was mostly found in rod-shaped and granular structures distrib-
uted throughout the cytoplasm. The green fluorescence followed a similar
pattern but overall gave a more blurred image, suggesting also some extra-
mitochondrial localization. Pretreatment of cardiomyocytes with 1 µM decameric
vanadate (i.e., 10 µM total vanadium) for 24 hours had a dramatic effect on
the red fluorescence, which now became very faint (Soares et al, in revision
process). It was verified that 24 h incubation of cardiomyocytes with decavanadate
and metavanadate solutions, induces the collapse of Ym, with the same IC50
value of 6.5 µM total vanadium (i.e. 0.65 µM decameric vanadate or 6.5 µM
monomeric vanadate). In addition, mitochondria membrane depolarization is
likely underlying the observed rise of basal cytosolic calcium and partial
depletion of intracellular calcium stores upon incubation of cardiomyocytes
with decavanadate or metavanadate solutions, as mitochondria membrane
depolarization leads to mitochondrial calcium release and also IP3-mediated
endoplasmic reticulum release in cardiomyocytes.
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Conclusions
We have found that incubation of cardiomyocytes with either decavanadate
or metavanadate solutions for 24 h produced large changes in two major
bioenergetic markers in these cells: (i) basal cytosolic Ca2+ concentration, and
(ii) mitochondrial production of superoxide anion. In this study, we also
verified that 24 h incubation of cardiomyocytes with decavanadate and
metavanadate solutions induce the collapse of Ym, with the same IC50 value
of 6.5 µM. Thus, our results strongly suggest that mitochondrial membrane
depolarization is a key event in decavanadate- and metavanadate-induced
cardiomyocytes death, which is noticeable after 24 h incubation with concen-
trations as low as 2 µM total vanadium. In conclusion, exposure to micromolar
concentrations of vanadate (added from decavanadate or metavanadate solu-
tions) induces cell death in isolated neonatal rat ventricular myocytes through
a similar toxic pathway, leading to mitochondrial membrane depolarization
and resulting in necrotic cell death.
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